Abdominal fat partitioning and high-molecular-weight adiponectin in short children born small for gestational age

Lourdes Ibáñez1, Abel López-Bermejo, Marta Díaz

  • 1Endocrinology Unit, Hospital Sant Joan de Déu, University of Barcelona, Passeig de Sant Joan de Déu, 2, 08950 Esplugues, Barcelona, Spain. libanez@hsjdbcn.org

Insights

Short small for gestational age (SGA) children exhibit high insulin sensitivity and reduced subcutaneous fat, unlike those who achieve catch-up growth. Further research is needed on growth hormone therapy effects.

Area of Science:

  • Pediatric Endocrinology
  • Metabolic Health
  • Growth Disorders

Background:

  • Children born small for gestational age (SGA) often experience metabolic changes post-catch-up growth, including hyperinsulinemia and increased visceral fat.
  • Limited data exists on SGA children who do not spontaneously achieve catch-up growth.

Purpose of the Study:

  • To investigate the metabolic and body composition profiles of SGA children who failed to achieve spontaneous catch-up growth.
  • To compare these profiles with appropriate-for-gestational-age (AGA) children and SGA children who achieved catch-up growth.

Main Methods:

  • Cross-sectional study comparing three groups: short SGA children, AGA children, and catch-up SGA children.
  • Measurements included fasting glucose, insulin, IGF-I, high-molecular-weight (HMW) adiponectin, body composition (absorptiometry), and abdominal fat distribution (MRI).

Main Results:

  • Short SGA children displayed significantly higher insulin sensitivity and lower IGF-I levels compared to both AGA and catch-up SGA groups.
  • These children had reduced subcutaneous (sc) abdominal fat and a markedly elevated visceral to sc fat ratio, despite a normal amount of visceral fat.
  • Circulating HMW adiponectin levels were high-normal in short SGA children, contrasting with expected lower levels.

Conclusions:

  • Short SGA children without catch-up growth exhibit a distinct metabolic and body composition phenotype characterized by insulin hypersensitivity and altered abdominal fat partitioning.
  • This phenotype differs significantly from SGA children who achieve catch-up growth.
  • The potential impact of growth hormone therapy on these specific features warrants further investigation.
Abstract

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight, compared...
Pharmacokinetics in Obese Patients: Drug Absorption and Distribution01:25

Pharmacokinetics in Obese Patients: Drug Absorption and Distribution

Obesity significantly alters the pharmacokinetic processes of drug absorption and distribution, presenting unique challenges in medical treatment. The increased fat tissue and decreased lean muscle in obese individuals can significantly affect how drugs are absorbed into the body and distributed across different tissues. This alteration can lead to variances in the effectiveness and safety of medications, necessitating adjustments in dosing or drug selection for obese patients.One notable...
Signs of Puberty01:27

Signs of Puberty

Puberty is a critical phase, typically beginning between the ages of 8 and 13 in girls and 9 and 14 in boys, though timing can vary based on genetics, environmental factors, and overall health. This period is characterized by the development of secondary sexual characteristics and the attainment of reproductive potential. Endocrine changes underpin puberty, with hormonal surges of Luteinizing Hormone (LH) and Follicle-Stimulating Hormone (FSH) instigated by Gonadotropin-Releasing Hormone (GnRH)...